BioPharm Asia, Inc. (DOMR.OB) Announces Substantial Growth in Revenues and Income
BioPharm Asia, Inc., a major retailer and wholesale distributor of medical products in China, today announced its financial results for the second quarter and six months ended June 30, 2009. For the second quarter, revenues were $19.9 million, up 22.0% from the $16.3 million generated during the second quarter of 2008. For the six months ended June 30, 2009, revenues totaled $42.6 million, up 27.5% from the prior year, largely due to an increase in wholesale revenues. Gross profit for the quarter was $5.9 million, up 12.6% from the comparable period last year. For the first six months, gross profits…